Invention Grant
- Patent Title: Constructs targeting histone H3 peptide/MHC complexes and uses thereof
-
Application No.: US16477509Application Date: 2018-01-11
-
Publication No.: US11274157B2Publication Date: 2022-03-15
- Inventor: Vivien Wai-Fan Chan , Hong Liu , Yoko Nakano , Yiyang Xu
- Applicant: EUREKA THERAPEUTICS, INC.
- Applicant Address: US CA Emeryville
- Assignee: EUREKA THERAPEUTICS, INC.
- Current Assignee: EUREKA THERAPEUTICS, INC.
- Current Assignee Address: US CA Emeryville
- Agency: Morrison & Foerster LLP
- International Application: PCT/US2018/013362 WO 20180111
- International Announcement: WO2018/132597 WO 20180719
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/725 ; C07K14/705 ; C07K16/46 ; A61K47/68 ; A61K35/17 ; G01N33/569 ; G01N33/574 ; A61K39/00
Abstract:
The present application provides constructs comprising an antibody moiety that specifically binds to a complex comprising a histone H3 peptide and an MHC class I protein. Also provided are methods of making and using these constructs.
Public/Granted literature
- US20190338035A1 CONSTRUCTS TARGETING HISTONE H3 PEPTIDE/MHC COMPLEXES AND USES THEREOF Public/Granted day:2019-11-07
Information query
